The original content of Democracy Now! Headlines appears under the Creative
Commons BY-NC-ND 3.0 License (United States). For more, including their other
shows and media, visit www.democracynow.org.
September 28, 2012

Report: Payments to Settle Fraud by U.S. Drugmakers Have Doubled in 2012 
-------------------------------------------------------------------------


 
A new report finds U.S. drugmakers have paid $6.6 billion dollars in
penalties and fees to settle fraud allegations this year, already
doubling what they paid last year. The advocacy group Public Citizen
said the increased fees and penalties are still not enough to make a
dent in drug company profits or to curb alleged behavior ranging from
overcharging Medicare to encouraging the prescription of drugs for
unsanctioned uses. In July, Glaxo Smith Kline settled for a record $3
billion over fraud charges, including allegations it failed to report
key safety data on a diabetes drug linked to heart risks.

 

.